The Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

Dec 3, 2019 - Dec 6, 2019
Fukuoka International Congress Center・Fukuoka sunpalace hotel & hall・Marine Messe Fukuoka

[3P-0286] Combination with EGFR-TKI and Trametinib, a MEK inhibitor, overcomes resistance to EGFR-TKI in NSCLC

〇Kenji Takeuchi1, Satsuki Asada1, Nanami Yoshimura1, Marika Banba1, Saki Shimizu1 (1.Dept. of Biochem., Fac. of Pharm. Sci., Setsunan Univ.)

EGFR-TKI

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password